Akbar, NoorSiddiqui, RuqaiyyahEl-Gamal, Mohammed I.Zaraei, Seyed-OmarSaeed, Balsam QubaisAlawfi, Bader SaleemKhan, Naveed Ahmed2024-05-192024-05-1920241383-57691873-0329https://doi.org10.1016/j.parint.2023.102814https://hdl.handle.net/20.500.12713/4602Acanthamoeba are ubiquitously distributed in the environment and can cause infection of the central nervous system as well a sight-threatening eye infection. Herein, the potential anti-amoebic activity of a series of sulfonate/sulfamate derivatives against pathogenic A. castellanii was evaluated. These compounds were tested using several assays namely amoebicidal, adhesion, excystation, cytotoxic, and cytopathogenicity. Amoebicidal assays revealed that the selected compounds reduced amoebae viability significantly (P < 0.05), and exhibited IC50 values at two-digit micromolar concentrations. Sulfamate derivatives 1j & 1k inhibited 50% of amoebae at 30.65 mu M and 27.21 mu M, respectively. The tested compounds blocked amoebae binding to host cells as well as inhibited amoebae excystation. Notably, the selected derivatives exhibited minimal human cell cytotoxicity but reduced parasite-mediated host cell damage. Overall, our study showed that sulfamate derivatives 1j & 1k have anti-amoebic potential and offer a promising avenue in the development of potential anti-amoebic drug candidates.eninfo:eu-repo/semantics/closedAccessAcanthamoeba CastellaniiSulfamateSulfonateAmoebicidalCytotoxicityCytopathogenicityArticle9837806551WOS:0011029879000012-s2.0-85173763880N/A10.1016/j.parint.2023.102814Q2